RxDoctor Payments Data

Meghan Sterett, PA

Physician Assistant · Augusta, GANPI 1558698258

Payments from drug & device makers

$3,399in general payments, 2019–2025

Across 205 payments — averaging $16.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$677
  • Novo Nordisk$425
  • Abbott$319
  • Lilly USA, LLC$286
  • Dexcom, Inc.$241
  • AstraZeneca$161
  • plus $1K from 26 others

What the payments were for

  • Food & beverage$3,399100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,399 in reported general payments places this provider in the 85th percentile of 3,581 physician assistant providers in Georgia.

See all physician assistant providers in Georgia

Medicare billing

Part B allowed, 2024
$14,723
Medicare patients
52
Services billed
1,907

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide17$16,106
MounjaroTirzepatide15$14,823
Albuterol Sulfate HfaAlbuterol Sulfate18$492
Gabapentin13$302
Rosuvastatin Calcium23$237
Pantoprazole Sodium17$218
Fluticasone Propionate11$196
Levothyroxine Sodium18$186
Tizanidine Hcl33$177
Diclofenac Sodium23$164
Sertraline Hcl18$160
Hydroxyzine Hcl17$146
Amlodipine Besylate38$146
Omeprazole19$122
Metformin Hcl17$108

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$425$16,10617 claims
Lilly USA, LLCMounjaro$286$14,82315 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,581 physician assistant providers in Georgia.

Other physician assistant in Augusta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →